cbdMD, Inc. produces and distributes various cannabidiol (CBD) products.
$0.42+7.22%
报价 2026-11-06
市值
$4.7M
EV
$4.4M
PE (TTM)
–
预期 PE (FY2027)
–
52 周区间距高点 -81.7%
$0.35$2.27
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| YCBDcbdMD, Inc. | $4.7M | +7.2% | +7.1% | 54.7% | – | – | – | |
| BFRIBiofrontera Inc. | $12.3M | +2.5% | +14.7% | 82.8% | – | – | – | |
| SBFMSunshine Biopharma, Inc. | $5.8M | -2.9% | – | 29.8% | – | – | – | |
| SNOASonoma Pharmaceuticals, Inc. | $5.3M | +3.7% | +15.5% | 38.9% | – | – | – | |
| CDIOCardio Diagnostics Holdings, Inc. | $4.9M | -1.4% | +4900.0% | -555% | – | – | – | |
| NRSNNeuroSense Therapeutics Ltd. | $3.2M | +20.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +15.5% | 29.8% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q3 2026 | 2026-03-31 Q2 2026 | 2025-12-31 Q1 2026 | 2025-09-30 Q4 2025 | 2025-06-30 Q3 2025 | 2025-03-31 Q2 2025 | 2024-12-31 Q1 2025 | 2024-09-30 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $5.6M | $5M | $4.7M | $4.6M | $4.7M | $5.1M | $4.6M |
| Gross Margin | 54.7% | 53.3% | 59.8% | 58.8% | 61.5% | 62.3% | 66.5% | 52.2% |
| Operating Margin | -20.4% | -14.2% | -5.7% | -14.5% | -19.6% | -10.2% | -1.7% | -5.5% |
| Net Income | $-1.1M | $-797,978 | $-283,131 | $-679,968 | $-895,272 | $-480,757 | $15,095 | $-152,799 |
| Diluted EPS | -0.11 | -0.08 | -0.04 | -0.08 | -0.21 | -0.19 | -0.22 | -0.27 |
| Operating Cash Flow | $-442.2M | $-722,500 | $-812,464 | $-240,749 | $-704,200 | $-189,477 | $-317,949 | $167,377 |